Skye Bioscience (SKYE) Misses Q3 EPS by 32c

Skye Bioscience (NASDAQ: SKYE) reported Q3 EPS of ($0.32).

For earnings history and earnings-related data on Skye Bioscience (SKYE) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Rocket Lab wins $12M in Space Force contracts for satellite network
• Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance